GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 408 filers reported holding GLOBUS MED INC in Q4 2023. The put-call ratio across all filers is 0.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $8,860,003 | +433.3% | 129,362 | +317.7% | 0.05% | +475.0% |
| Q1 2024 | $1,661,392 | -71.5% | 30,973 | -71.7% | 0.01% | -75.8% |
| Q4 2023 | $5,824,011 | -17.2% | 109,289 | -22.9% | 0.03% | -23.3% |
| Q3 2023 | $7,037,192 | +38.5% | 141,736 | +66.1% | 0.04% | +38.7% |
| Q2 2023 | $5,079,417 | -4.7% | 85,311 | -9.4% | 0.03% | -6.1% |
| Q1 2023 | $5,332,656 | -20.9% | 94,150 | +3.7% | 0.03% | -10.8% |
| Q4 2022 | $6,745,870 | -6.7% | 90,829 | -25.2% | 0.04% | 0.0% |
| Q3 2022 | $7,234,000 | +2.9% | 121,441 | -3.0% | 0.04% | +23.3% |
| Q2 2022 | $7,030,000 | -16.0% | 125,220 | +10.3% | 0.03% | -11.8% |
| Q1 2022 | $8,373,000 | +33.8% | 113,486 | +30.9% | 0.03% | -5.6% |
| Q4 2021 | $6,258,000 | -11.1% | 86,679 | -5.7% | 0.04% | -7.7% |
| Q3 2021 | $7,043,000 | -8.6% | 91,916 | -7.5% | 0.04% | -20.4% |
| Q2 2021 | $7,708,000 | – | 99,420 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sterling Investment Advisors, Ltd. | 327,723 | $13,863,000 | 7.09% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 944,700 | $39,960,000 | 3.64% |
| Godshalk Welsh Capital Management, Inc. | 85,108 | $3,600,000 | 3.33% |
| NUANCE INVESTMENTS, LLC | 1,316,057 | $55,669,000 | 2.36% |
| Global Alpha Capital Management Ltd. | 264,350 | $11,182,000 | 1.94% |
| BROADVIEW ADVISORS LLC | 147,275 | $6,230,000 | 1.92% |
| Van Berkom & Associates Inc. | 1,476,695 | $62,464,000 | 1.81% |
| Pembroke Management, LTD | 319,037 | $13,495,000 | 1.42% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $8,460,000 | 1.28% |
| OAK RIDGE INVESTMENTS LLC | 408,731 | $17,289,000 | 1.20% |